Pakistani and Chinese experts have done the successful clinical trial of the first traditional Chinese medicine (TCM) “Yinhuang Qingfei Capsules” in Pakistan as a ‘revolutionary step’ in the country’s healthcare system.
In-charge of the clinical trial project Prof. Dr. M. Raza Shah said in a press conference held in Karachi that “The herb-based Chinese medicine will be an efficient alternative for antibiotics currently recommended for chronic bronchitis”.
He shared the details of clinical confirmatory trials that they were conducted by the Center for Bio equivalence Studies and Clinical Research (CBSCR), which works as a component of Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi to introduce the effective treatment strategies and drugs for patients with chronic bronchitis in Pakistan.
He mentioned that the clinical trial was carried out by using randomized, double-blind, double-simulation positive control study to assess the efficacy and effectiveness of Yinhuang Qingfei Capsules on patients with acute exacerbation of chronic bronchitis in Pakistan.
He informed that total of 212 patients (aged 18 to 65) with an acute attack of chronic bronchitis were selected and diagnosed and evaluated according to the criteria of western medicine.
The press conference held at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi was attended by number of medical experts from Pakistan and China
“Yinhuang Qingfei Capsules” was a natural herbs preparation developed by Hunan Anbang Pharmaceutical for the treatment of an acute attack of chronic bronchitis.
Chronic bronchitis is a common disease related to chronic inflammation, which is caused by a variety of pathogenic factors, such as air pollution, smoking, and pathogen infection.
Director of the ICCBS Prof. Dr. Muhammad Iqbal Choudhary said the trial of a traditional Chinese medicine for the first time in Pakistan is a historic step which will open new opportunities of cooperation in the field of medicine between the two countries.
He further said “Because of its satisfactory clinical efficacy, as the main component of complementary and alternative drug therapy, herbal preparation of natural medicine has drawn more attention from all over the world, which has also played an important role in the prevention and treatment of chronic bronchitis”.
Chairman of the Hunan Federation of Industry and Commerce Zhang Jian told the audience that the success of the clinical trial shows that Chinese patent medicine has officially entered Pakistan.
Chairman of Anbang Pharmaceutical Chen Feibao said the effectiveness of Yinhuang Qingfei capsule to treat Chronic Obstructive Pulmonary Disease is higher than its competitor western medicine but its price is only 5 percent of that which will reduce the financial burden on Pakistani patients.
Chinese experts present on the occasion said the traditional capsule was a natural herb preparation developed for the treatment of acute attack of chronic bronchitis.